VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: China's CXMT Prices Record $8.5B Shanghai Chip IPO
Value Add VC/Pulse/IPO~$8.5B raised

China's CXMT Prices Record $8.5B Shanghai Chip IPO

China's DRAM champion ChangXin Memory Technologies priced an $8.5 billion IPO on Shanghai's STAR Market, implying an $85 billion valuation and becoming the venue's second-largest listing ever, with trading set to begin July 27.

By the Numbers

~$8.5B (57.9B yuan)
Raise
~$85B
Implied valuation
7.7%
Global DRAM share
Jul 27, 2026
Trading begins
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 22, 2026
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

ChangXin Memory Technologies (CXMT), China's largest DRAM memory-chip maker, priced shares at 8.66 yuan, raising roughly 57.9 billion yuan ($8.5 billion) on Shanghai's STAR Market, with trading set to begin July 27

2

The offering implies a valuation of roughly 579 billion yuan ($85 billion), making CXMT's IPO the STAR Market's second-largest ever, trailing only Semiconductor Manufacturing International Corporation's 2020 debut

3

CXMT holds an estimated 7.7% global DRAM market share, ranking as the world's fourth-largest memory producer, and the listing is widely read as China building domestic chip-supply resilience amid ongoing US export controls on advanced semiconductor equipment

4

The scale of the raise -- among the largest tech listings anywhere in 2026 -- underscores that China's semiconductor self-sufficiency push is attracting serious domestic capital even as geopolitical tension over AI chips and export controls escalates on a separate track

TC

The VC Read · Trace's Take

Trace Cohen

An $85B implied valuation for a DRAM maker most US investors have never heard of should be a bigger story than it is -- China just proved its chip self-sufficiency push has real domestic capital behind it, not just state subsidy talk. This lands the same week as the Moonshot distillation accusation, and together they're the same story: the US-China AI stack is bifurcating fast, on hardware and on models simultaneously. Founders building cross-border AI hardware supply chains should be planning for two separate ecosystems, not one.

AI Chip Wars →

Analysis

ChangXin Memory Technologies, China's largest DRAM memory-chip maker, priced shares at 8.66 yuan for its IPO on Shanghai's STAR Market, raising roughly 57.9 billion yuan -- about $8.5 billion -- with trading set to begin July 27. The offering implies a valuation of roughly 579 billion yuan, or approximately $85 billion, making it the STAR Market's second-largest IPO ever, trailing only Semiconductor Manufacturing International Corporation's 2020 debut.

CXMT, based in Hefei, Anhui province, holds an estimated 7.7% of the global DRAM market, ranking it as the world's fourth-largest memory producer behind Samsung, SK hynix and Micron. The scale and timing of this listing -- one of the largest tech IPOs anywhere in 2026 -- reflects China's deliberate push to build domestic chip-supply resilience as US export controls on advanced semiconductor equipment continue to constrain what Chinese chipmakers can access from Western suppliers.

The demand for the offering was reportedly intense, drawing what multiple outlets described as massive investor subscription and a high expected allotment rate -- a signal that domestic Chinese capital is willing to fund semiconductor self-sufficiency at scale even without direct access to the most advanced Western fabrication equipment. This lands the same month SK hynix, the Korean chipmaker behind much of the world's AI-accelerator memory, completed its own record US ADR listing, putting two of the world's largest memory makers into public markets within weeks of each other.

For semiconductor and geopolitics-focused investors, CXMT's listing is a data point that China's chip self-sufficiency strategy has real domestic capital-markets support behind it, not just state subsidy, even as the broader US-China AI and chip tension escalates on a separate track -- including this same week's accusations that Moonshot AI improperly distilled Anthropic's Fable model. Watch for how CXMT shares trade on their July 27 debut relative to the IPO price, and whether the strong subscription demand translates into a durable aftermarket, or a first-day pop followed by a fade, as has happened to some other 2026 mega-listings.

ShareXLinkedInEmail

More on

ChangXin Memory Technologies →

Reported by South China Morning Post · First reported by Shanghai Stock Exchange · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 9, 2026

What BofA's Extreme Bull Signal Means for Your Marks

Illustration for: What BofA's Extreme Bull Signal Means for Your Marks
IPO

What BofA's Extreme Bull Signal Means for Your Marks

BofA's Bull & Bear indicator hit 9.7, its highest since 2021 and above the firm's own 8.0 sell threshold — a trace's-take on what that extreme reading should change about how GPs mark portfolio companies against public comps.

IPO· Aug 8, 2026

Biotech IPOs Are Pricing Above Range Again

Illustration for: Biotech IPOs Are Pricing Above Range Again
IPO$532.5M combined

Biotech IPOs Are Pricing Above Range Again

BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

@Trace_Cohen·t@nyvp.com